By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > GMJ Briefs > UK Issues New Guidance on Andes Hantavirus as South American Cases Rise
Global HealthPolicy & Systems

UK Issues New Guidance on Andes Hantavirus as South American Cases Rise

GMJ
Last updated: 15/06/2026 11:43
By
Prof. Giorgi Pkhakadze
Share
0 Min Read
SHARE
3 min read|627 words
✓ Editorially Reviewed by Prof. Giorgi Pkhakadze, MD, MPH, PhD — GMJ News Desk

🟠 Moderate Evidence

The UK government has released updated guidance on Andes hantavirus, the only hantavirus known to transmit between humans, as health authorities monitor ongoing outbreaks in South America. The UK Health Security Agency guidance emphasises the virus’s unique person-to-person transmission capability among hantaviruses.

Key takeaways

  • Andes hantavirus is the only hantavirus species capable of human-to-human transmission
  • The virus causes hantavirus pulmonary syndrome with mortality rates reaching 30-40%
  • Endemic to South America, particularly Chile and Argentina, with sporadic outbreaks reported
30-40%
mortality rate for Andes hantavirus pulmonary syndrome according to UK Health Security Agency

Unique transmission pattern sets virus apart

Unlike other hantaviruses that spread only through rodent contact, Andes hantavirus demonstrates documented person-to-person transmission, according to the UK Health Security Agency. The virus is endemic to South America, with the long-tailed pygmy rice rat serving as the primary reservoir host.

The guidance highlights that while most hantaviruses require direct contact with infected rodent excreta, Andes hantavirus can spread between humans through close contact with infected individuals. This transmission pattern has been documented in several outbreak investigations across South American countries.

Submit Your Paper
GMJ_Submit_Banner

Clinical presentation and diagnostic challenges

Andes hantavirus infection progresses through distinct phases, beginning with fever, headache, and muscle pain before advancing to severe respiratory complications. The Centers for Disease Control and Prevention notes that hantavirus pulmonary syndrome typically develops 1-5 weeks after exposure.

Early symptoms often resemble flu-like illness, making initial diagnosis challenging for clinicians. The UK guidance emphasises the importance of travel history and potential exposure when evaluating patients with compatible symptoms. Healthcare providers should maintain high clinical suspicion in patients with recent travel to endemic regions.

Hantavirus Endemic Regions

Geographic distribution of Andes hantavirus cases in South America

Chile
Primary endemic area
Argentina
Secondary endemic area
Person-to-person
Unique transmission

Source: UK Health Security Agency, 2024 | Georgian Medical Journal News

Public health response and prevention

The UK guidance outlines specific infection control measures for healthcare settings, including isolation precautions for suspected cases. Contact tracing becomes particularly important given the virus’s human-to-human transmission capability, unlike other hantavirus species that spread only through rodent exposure.

Prevention strategies focus on avoiding contact with rodents and their excreta in endemic areas, alongside standard infection control measures when caring for suspected patients. The World Health Organization recommends enhanced surveillance in areas with known rodent reservoir populations.

Andes hantavirus represents the only hantavirus species with documented sustained human-to-human transmission, distinguishing it from other members of the hantavirus family

— UK Health Security Agency (Government Guidance, 2024)

What this means

For patients: Travellers to South America should avoid contact with rodents and seek immediate medical attention for fever and respiratory symptoms after potential exposure
For clinicians: Maintain high clinical suspicion for hantavirus in patients with compatible symptoms and travel history to endemic regions, implementing appropriate isolation measures
For policymakers: Enhanced surveillance systems and international cooperation are essential for monitoring outbreaks of this human-transmissible hantavirus strain

Frequently asked questions

How does Andes hantavirus differ from other hantaviruses?

Andes hantavirus is unique among hantaviruses because it can transmit between humans through close contact. Other hantavirus species only spread through contact with infected rodent droppings, urine, or saliva.

What are the early symptoms of Andes hantavirus infection?

Initial symptoms include fever, headache, muscle aches, and fatigue, resembling flu-like illness. Severe respiratory symptoms typically develop 1-5 weeks after exposure as the infection progresses to hantavirus pulmonary syndrome.

Is there treatment available for Andes hantavirus?

Currently, no specific antiviral treatment exists for hantavirus infections. Management focuses on supportive care, particularly respiratory support for patients who develop pulmonary syndrome.

The updated UK guidance reflects growing international awareness of emerging infectious diseases with pandemic potential. As global travel increases and climate patterns shift, health authorities emphasise the importance of robust surveillance systems to detect and respond to outbreaks of zoonotic diseases like Andes hantavirus.

Source: Andes hantavirus: epidemiology, outbreaks and guidance

Was this article helpful?

Related Coverage

Insulin Remains Inaccessible to Millions Despite Century of ProgressJun 15, 2026
Eswatini Targets Malaria Elimination by 2028 as WHO Reports 2.3 Billion Cases Averted Since 2000Jun 15, 2026
MHRA Reports Progress on Health Equity Through Regulatory ReformJun 15, 2026
FDA Issues 47 Medical Device Safety Alerts in 2024, Highlighting Critical Patient Safety RisksJun 15, 2026
TAGGED:hantavirusInfectious Diseasepublic healthSouth AmericaUK guidance
Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Finerenone Shows Cardiovascular Benefits in Non-Diabetic Chronic Kidney Disease Patients

Finerenone significantly reduces cardiovascular events by 14% in non-diabetic chronic kidney disease…

Pediatric influenza hospitalizations nearly doubled post-pandemic, Canadian surveillance finds

Canadian surveillance study reveals pediatric influenza hospitalizations nearly doubled in 2022–2023, with…

Trump’s Perfect Cognitive Test Score: What Montreal Cognitive Assessment Really Measures

President Trump's perfect 30/30 score on cognitive testing prompts medical experts to…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Global HealthPolicy & Systems

Australia confirms first diphtheria death as outbreak reaches worst level in decades

By
Prof. Giorgi Pkhakadze
26/05/2026
Global HealthPolicy & Systems

WHO Experts Challenge US-Uganda Ebola Containment Strategy Based on Geographic Barriers

By
Prof. Giorgi Pkhakadze
30/05/2026
Global HealthPolicy & Systems

PAHO activates Ebola preparedness protocols across Americas following Africa outbreak

By
Prof. Giorgi Pkhakadze
07/06/2026
Global HealthPolicy & Systems

WHO Declares Health Emergency as Ebola Outbreak Spreads from DRC to Uganda

By
Prof. Giorgi Pkhakadze
31/05/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up